[go: up one dir, main page]

SE0203551D0 - Prothrombin purification - Google Patents

Prothrombin purification

Info

Publication number
SE0203551D0
SE0203551D0 SE0203551A SE0203551A SE0203551D0 SE 0203551 D0 SE0203551 D0 SE 0203551D0 SE 0203551 A SE0203551 A SE 0203551A SE 0203551 A SE0203551 A SE 0203551A SE 0203551 D0 SE0203551 D0 SE 0203551D0
Authority
SE
Sweden
Prior art keywords
prothrombin
solution
factor
relates
fraction
Prior art date
Application number
SE0203551A
Other languages
English (en)
Inventor
Stefan Winge
Peter Aizawa
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0203551A priority Critical patent/SE0203551D0/sv
Publication of SE0203551D0 publication Critical patent/SE0203551D0/sv
Priority to AU2003267907A priority patent/AU2003267907A1/en
Priority to PCT/SE2003/001549 priority patent/WO2004050904A1/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE0203551A 2002-12-02 2002-12-02 Prothrombin purification SE0203551D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0203551A SE0203551D0 (sv) 2002-12-02 2002-12-02 Prothrombin purification
AU2003267907A AU2003267907A1 (en) 2002-12-02 2003-10-06 Prothrombin purification
PCT/SE2003/001549 WO2004050904A1 (en) 2002-12-02 2003-10-06 Prothrombin purification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0203551A SE0203551D0 (sv) 2002-12-02 2002-12-02 Prothrombin purification

Publications (1)

Publication Number Publication Date
SE0203551D0 true SE0203551D0 (sv) 2002-12-02

Family

ID=20289726

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0203551A SE0203551D0 (sv) 2002-12-02 2002-12-02 Prothrombin purification

Country Status (3)

Country Link
AU (1) AU2003267907A1 (sv)
SE (1) SE0203551D0 (sv)
WO (1) WO2004050904A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710321D0 (en) 2007-05-30 2007-07-11 Nhs Blood & Transplant Method
US9956272B2 (en) 2007-05-30 2018-05-01 Bio Products Laboratory Limited Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
CA2793136C (en) * 2010-03-30 2019-05-07 Gustav Gilljam A process for purifying vitamin k dependent proteins such as coagulation factor ix
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
CA3080656A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
US5219995A (en) * 1992-07-14 1993-06-15 Alpha Therapeutic Corporation Plasma fraction purification
ES2241030T3 (es) * 1996-03-20 2005-10-16 Baxter Aktiengesellschaft Preparado farmaceutico para el tratamiento de alteraciones de la coagulacion sanguinea.
JPH11228443A (ja) * 1998-02-07 1999-08-24 Chemo Sero Therapeut Res Inst 新規なプロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
US6245548B1 (en) * 2000-03-09 2001-06-12 American National Red Cross Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate

Also Published As

Publication number Publication date
AU2003267907A1 (en) 2004-06-23
WO2004050904A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
ATE268766T1 (de) Stickstoff enthaltende heterobicyclen als factor xa inhibitoren
GB0216001D0 (en) Process and composition
PL1841863T3 (pl) Sposób oczyszczania czynnika VII
WO2002000651A3 (en) Factor xa inhibitors
AU2003299519A1 (en) Hepatitis c virus inhibitors
AU2002248384A1 (en) Serpin drugs for treatment of hiv infection and method of use thereof
EP1568710A3 (en) Antibody purification method
NO20044889L (no) Inhibitorer av serinproteaser, spesielt HCV NS3-NS4A-protease
ATE380175T1 (de) Pyrrolidine als dipeptidyl peptidase inhibitoren
SE9603068D0 (sv) Process for purifying a protein
DK1268498T3 (da) Kardioprotektive phosphater
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
AU2002354696A1 (en) Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme
MY128271A (en) Purification method for (meth) acrylic acid
GB0216002D0 (en) Process and composition
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
HK1121670A1 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
ATE382592T1 (de) Verfahren zur aufreinigung von (hydro)halogenkohlenstoffen
SE0203551D0 (sv) Prothrombin purification
AU8184301A (en) Inhibitors for the blood-clotting factor xa
WO2002030983A3 (de) Bikunin enthaltende plasmafraktion, verfahren zu ihrer herstellung und ihrer verwendung
WO2002002519A3 (en) THROMBIN OR FACTOR Xa INHIBITORS
MY132553A (en) Methods of making hiv-protease inhibitors and intermediates for making hiv-protease inhibitors
SE0201207D0 (sv) A process for production of a regioselective membrane
DE60310240D1 (de) Entfernung von prionen-infektiosität